Asymptomatic COVID‐19: disease tolerance with efficient anti‐viral immunity against SARS‐CoV‐2

The immune responses and mechanisms limiting symptom progression in asymptomatic cases of SARS‐CoV‐2 infection remain unclear. We comprehensively characterized transcriptomic profiles, cytokine responses, neutralization capacity of antibodies, and cellular immune phenotypes of asymptomatic patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Yi‐Hao, Fong, Siew‐Wai, Poh, Chek‐Meng, Carissimo, Guillaume, Yeo, Nicholas Kim‐Wah, Amrun, Siti Naqiah, Goh, Yun Shan, Lim, Jackwee, Xu, Weili, Chee, Rhonda Sin‐Ling, Torres‐Ruesta, Anthony, Lee, Cheryl Yi‐Pin, Tay, Matthew Zirui, Chang, Zi Wei, Lee, Wen‐Hsin, Wang, Bei, Tan, Seow‐Yen, Kalimuddin, Shirin, Young, Barnaby Edward, Leo, Yee‐Sin, Wang, Cheng‐I, Lee, Bernett, Rötzschke, Olaf, Lye, David Chien, Renia, Laurent, Ng, Lisa F P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185544/
https://www.ncbi.nlm.nih.gov/pubmed/33961735
http://dx.doi.org/10.15252/emmm.202114045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185544/
https://www.ncbi.nlm.nih.gov/pubmed/33961735
http://dx.doi.org/10.15252/emmm.202114045

Ejemplares similares